Altair
Skip to content

Trading Analysis Report: ORCL

Analysis date: 2026-10-08 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-08
  • Rating: Underweight
  • Generated: 2026-10-09 04:01:17
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-opus-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Underweight

Executive Summary: Underweight ORCL at the deep end of the range. Do not wait for a bounce. Today, cut to a hedged core sized so that the worst case through mid-January costs no more than 3.5% of a standard position: about 0.34x with a January 127 put / 163 call collar, or about 0.27x as a put-only hedge if the 163 call is cheap. Leave at most 0.15x resting at 139-140, and sell it by the close before September CPI or on a daily close below 131.58; options-restricted accounts go to about 0.10x. Take no new longs and no short stock where ORCL is held, cut the core to 0.15x on Oracle-specific financing, credit, cash or OpenAI triggers, and rebuild only after a clean mid-December FY27 Q2 print; the action horizon is about 3 months and the 12-month value target is $143, below the hurdle return.

Current Price: 135.69

Price Target: 143.0

Confidence: Medium

Time Horizon: 3-12 months

7. Risks and catalysts

Supporting the stock: - Revenue growth has accelerated for four straight reported quarters, and margins are widening at the same time, which supports the case that strong AI and cloud demand is turning into revenue. - The jump in operating cash flow, if it comes from customer prepayments, is a sign of real, committed demand. - Raising equity lowers balance-sheet risk. Equity/assets nearly doubled in a year and liquidity is comfortable.

Risks: - Free cash flow has been negative for four reported quarters in a row (FY26 Q4 is missing), and capex is still accelerating. Oracle depends on capital markets to fund itself. - Dilution and more issuance: about 5% more diluted shares YoY, with further equity raises possible. Ongoing issuance could weigh on the share price. - Depreciation still to come: about $59B+ of capex in the last three reported quarters will be depreciated as it comes into service. That could push down the 34.8% operating margin in FY27–FY28. - Operating cash flow quality: if the FY27 Q1 inflow came from prepayments, it may reverse and free cash flow would worsen. - Liabilities up $80B YoY, plus rising interest costs, as shown by the widening gap between operating income and net income. - Possible customer concentration in large AI contracts. The tools can't verify this, but it would matter given how fast capex is growing.

Next fundamental event: FY27 Q2 results for the quarter ending 2026-11-30, usually reported in mid-December.